Gene · 3702
Papers2,789
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 2,789
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Use of BTK Inhibitors in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): A Practical Guidance. | Blood Lymphat Cancer | 2022 | 35911566 | PubTator, text mining | PubMed |
| Genetic Contributors of Efficacy and Adverse Metabolic Effects of Chlorthalidone in African Americans from the Genetics of Hypertension Associated Treatments (GenHAT) Study. | Genes (Basel) | 2022 | 35886043 | PubTator, text mining | PubMed |
| Target-Based Small Molecule Drug Discovery for Colorectal Cancer: A Review of Molecular Pathways and In Silico Studies. | Biomolecules | 2022 | 35883434 | PubTator, text mining | PubMed |
| KSTAR: An algorithm to predict patient-specific kinase activities from phosphoproteomic data. | Nat Commun | 2022 | 35879309 | PubTator, text mining | PubMed |
| Pathogenic Variants in Cardiomyopathy Disorder Genes Underlie Pediatric Myocarditis-Further Impact of Heterozygous Immune Disorder Gene Variants? | J Cardiovasc Dev Dis | 2022 | 35877578 | PubTator, text mining | PubMed |
| A case report of pre-eclampsia-like endothelial injury in the kidney of an 85-year-old man treated with ibrutinib. | BMC Nephrol | 2022 | 35870899 | PubTator, text mining | PubMed |
| The first case of Streptococcus intermedius brain abscess with hemophagocytic histiocytosis. | BMC Infect Dis | 2022 | 35850669 | PubTator, text mining | PubMed |
| Identification of Novel Tumor Microenvironment Regulating Factor That Facilitates Tumor Immune Infiltration in Cervical Cancer. | Front Oncol | 2022 | 35847936 | PubTator, text mining | PubMed |
| Imagining the cell therapist: Future CAR T cell monitoring and intervention strategies to improve patient outcomes. | EJHaem | 2022 | 35844298 | PubTator, text mining | PubMed |
| Systems biology models to identify the influence of SARS-CoV-2 infections to the progression of human autoimmune diseases. | Inform Med Unlocked | 2022 | 35818398 | PubTator, text mining | PubMed |
| Bleeding Propensity in Waldenström Macroglobulinemia: Potential Causes and Evaluation. | Thromb Haemost | 2022 | 35817084 | PubTator, text mining | PubMed |
| Transcriptomic Correlates of Tumor Cell PD-L1 Expression and Response to Nivolumab Monotherapy in Metastatic Clear Cell Renal Cell Carcinoma. | Clin Cancer Res | 2022 | 35802667 | PubTator, text mining | PubMed |
| Gene Expression Signatures Reveal Common Virus Infection Pathways in Target Tissues of Type 1 Diabetes, Hashimoto's Thyroiditis, and Celiac Disease. | Front Immunol | 2022 | 35795668 | PubTator, text mining | PubMed |
| Identification of Immune-Related Hub Genes in Thymoma: Defects in CD247 and Characteristics of Paraneoplastic Syndrome. | Front Genet | 2022 | 35774508 | PubTator, text mining | PubMed |
| Analysis of Glaucoma Associated Genes in Response to Inflammation, an Examination of a Public Data Set Derived from Peripheral Blood from Patients with Hepatitis C. | Clin Ophthalmol | 2022 | 35770250 | PubTator, text mining | PubMed |
| Zanubrutinib in Treating Waldenström Macroglobulinemia, the Last Shall Be the First. | Ther Clin Risk Manag | 2022 | 35770040 | PubTator, text mining | PubMed |
| Differential regulation of CTLA4 expression through BTK-dependent and independent mechanisms in CLL. | Blood Adv | 2022 | 35759759 | PubTator, text mining | PubMed |
| A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma. | Cancer Discov | 2022 | 35758895 | PubTator, text mining | PubMed |
| Next-Generation Anti-Angiogenic Therapies as a Future Prospect for Glioma Immunotherapy; From Bench to Bedside. | Front Immunol | 2022 | 35757736 | PubTator, text mining | PubMed |
| Immunophenotypic Landscape and Prognosis-Related mRNA Signature in Diffuse Large B Cell Lymphoma. | Front Genet | 2022 | 35754837 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3702/papers?page=30